{"id": 225026464, "title": "Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stockholm", "text": "About Elevai Skincare Elevai Skincare Inc., an Elevai Labs company, is a medical aesthetics company developing and commercializing cutting-edge physician-dispensed skin and hair care applications. Elevai develops cosmetic products for the physician-dispensed market, with a focus on leveraging novel proprietary science-backed technologies, including its stem cell exosome technology. For more information, please visit www.elevaiskincare.com. Forward-Looking Statements Certain statements in this announcement are forward-looking statements, including, but not limited to, the Company\u2019s proposed Offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company\u2019s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs, including the expectation that our shares of common stock will start trading or that the Offering will be successfully completed. Investors can find many (but not all) of these statements using words such as \u201capproximates,\u201d \u201cbelieves,\u201d \u201chopes,\u201d \u201cexpects,\u201d \u201canticipates,\u201d \u201cestimates,\u201d \u201cprojects,\u201d \u201cintends,\u201d \u201cplans,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201cshould,\u201d \u201ccould,\u201d \u201cmay\u201d or other similar expressions in this prospectus. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company\u2019s registration statement and other filings with the SEC.", "summary": "NEWPORT BEACH, Calif., May 29, 2024 (GLOBE NEWSWIRE) &#8212; Elevai Labs Inc. (NASDAQ: ELAB) (\u201cElevai\u201d or the \u201cCompany\u201d), a pioneering force in medical aesthetics, announced that Chief Executive Officer Jordan R. Plews, PhD has been invited back and will be presenting at the Beauty Through Science conference in Stockholm, Sweden on Thursday May 30, 2024. [&#8230;]", "url": "https://financialpost.com/globe-newswire/elevai-labs-subsidiary-elevai-skincare-to-present-at-the-beauty-through-science-conference-in-stockholm", "image": "https://smartcdn.gprod.postmedia.digital/financialpost/wp-content/uploads/2024/05/commuters-on-bay-street-as-canadian-stocks-mixed.jpg?quality=5&strip=all&w=100&sig=gCsOruxPhrA8bPqdSVYb6g", "video": null, "publish_date": "2024-05-29 13:15:08", "author": "GlobeNewswire", "authors": ["GlobeNewswire"], "language": "en", "source_country": "CA", "sentiment": -0.57}